nodes	percent_of_prediction	percent_of_DWPC	metapath
Fencamfamine—SLC6A3—Parkinson's disease	0.833	1	CbGaD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—PITX3—Parkinson's disease	0.00813	0.0619	CbGpPWpGaD
Fencamfamine—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00786	0.274	CbGeAlD
Fencamfamine—SLC6A3—Clearance of dopamine—COMT—Parkinson's disease	0.00661	0.0503	CbGpPWpGaD
Fencamfamine—SLC6A3—Clearance of dopamine—MAOA—Parkinson's disease	0.00656	0.0499	CbGpPWpGaD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—LMX1A—Parkinson's disease	0.00616	0.0469	CbGpPWpGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—SNCAIP—Parkinson's disease	0.0051	0.0388	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—PINK1—Parkinson's disease	0.0051	0.0388	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—SEPT5—Parkinson's disease	0.0051	0.0388	CbGpPWpGaD
Fencamfamine—SLC6A3—nerve—Parkinson's disease	0.00495	0.173	CbGeAlD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—EN1—Parkinson's disease	0.00467	0.0355	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—SNCAIP—Parkinson's disease	0.00434	0.033	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—HTRA2—Parkinson's disease	0.00386	0.0294	CbGpPWpGaD
Fencamfamine—SLC6A3—hindbrain—Parkinson's disease	0.00371	0.13	CbGeAlD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—ATXN2—Parkinson's disease	0.00329	0.025	CbGpPWpGaD
Fencamfamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—Parkinson's disease	0.00301	0.0229	CbGpPWpGaD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—NR4A2—Parkinson's disease	0.00301	0.0229	CbGpPWpGaD
Fencamfamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—Parkinson's disease	0.00299	0.0228	CbGpPWpGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—PARK7—Parkinson's disease	0.00293	0.0223	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—GPR37—Parkinson's disease	0.00293	0.0223	CbGpPWpGaD
Fencamfamine—SLC6A3—Monoamine Transport—DBH—Parkinson's disease	0.00286	0.0217	CbGpPWpGaD
Fencamfamine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC18A2—Parkinson's disease	0.00271	0.0206	CbGpPWpGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—UCHL1—Parkinson's disease	0.00268	0.0204	CbGpPWpGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—GRK5—Parkinson's disease	0.00261	0.0199	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—PARK7—Parkinson's disease	0.00249	0.019	CbGpPWpGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—SNCA—Parkinson's disease	0.00234	0.0178	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—UCHL1—Parkinson's disease	0.00228	0.0173	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—LRRK2—Parkinson's disease	0.00222	0.0169	CbGpPWpGaD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—DDC—Parkinson's disease	0.00221	0.0168	CbGpPWpGaD
Fencamfamine—SLC6A3—brainstem—Parkinson's disease	0.00213	0.0742	CbGeAlD
Fencamfamine—Phenmetrazine—SLC6A3—Parkinson's disease	0.00209	0.295	CrCbGaD
Fencamfamine—SLC6A3—forebrain—Parkinson's disease	0.00205	0.0717	CbGeAlD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—SNCA—Parkinson's disease	0.00199	0.0152	CbGpPWpGaD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—SLC18A2—Parkinson's disease	0.00188	0.0143	CbGpPWpGaD
Fencamfamine—SLC6A3—Amine compound SLC transporters—SLC18A2—Parkinson's disease	0.00188	0.0143	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—DDC—Parkinson's disease	0.00183	0.0139	CbGpPWpGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—MAOB—Parkinson's disease	0.00181	0.0138	CbGpPWpGaD
Fencamfamine—Phendimetrazine—SLC6A3—Parkinson's disease	0.00173	0.244	CrCbGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—PARK2—Parkinson's disease	0.00167	0.0127	CbGpPWpGaD
Fencamfamine—SLC6A3—Monoamine Transport—ADORA2A—Parkinson's disease	0.00157	0.0119	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—PARK2—Parkinson's disease	0.00142	0.0108	CbGpPWpGaD
Fencamfamine—SLC6A3—midbrain—Parkinson's disease	0.00136	0.0473	CbGeAlD
Fencamfamine—Tranylcypromine—MAOB—Parkinson's disease	0.00133	0.188	CrCbGaD
Fencamfamine—SLC6A3—spinal cord—Parkinson's disease	0.00132	0.0462	CbGeAlD
Fencamfamine—SLC6A3—Dopaminergic Neurogenesis—TH—Parkinson's disease	0.00123	0.00937	CbGpPWpGaD
Fencamfamine—SLC6A3—Alpha-synuclein signaling—TH—Parkinson's disease	0.0012	0.00913	CbGpPWpGaD
Fencamfamine—SLC6A3—head—Parkinson's disease	0.00118	0.041	CbGeAlD
Fencamfamine—SLC6A3—Monoamine Transport—TH—Parkinson's disease	0.00117	0.0089	CbGpPWpGaD
Fencamfamine—SLC6A3—nervous system—Parkinson's disease	0.00111	0.0389	CbGeAlD
Fencamfamine—SLC6A3—central nervous system—Parkinson's disease	0.00107	0.0375	CbGeAlD
Fencamfamine—SLC6A3—cerebellum—Parkinson's disease	0.00105	0.0366	CbGeAlD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—TH—Parkinson's disease	0.00102	0.00776	CbGpPWpGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—CYCS—Parkinson's disease	0.000978	0.00745	CbGpPWpGaD
Fencamfamine—Tranylcypromine—MAOA—Parkinson's disease	0.000935	0.132	CrCbGaD
Fencamfamine—SLC6A3—Neuronal System—HCN3—Parkinson's disease	0.00088	0.0067	CbGpPWpGaD
Fencamfamine—SLC6A3—brain—Parkinson's disease	0.000852	0.0297	CbGeAlD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00074	0.00563	CbGpPWpGaD
Fencamfamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.000734	0.00559	CbGpPWpGaD
Fencamfamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000676	0.00514	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.000639	0.00486	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GSTA4—Parkinson's disease	0.000588	0.00448	CbGpPWpGaD
Fencamfamine—Tranylcypromine—CYP2E1—Parkinson's disease	0.000577	0.0814	CrCbGaD
Fencamfamine—SLC6A3—Neuronal System—KCNJ4—Parkinson's disease	0.000567	0.00432	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.0005	0.0038	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—DLG1—Parkinson's disease	0.000489	0.00373	CbGpPWpGaD
Fencamfamine—SLC6A3—Monoamine Transport—IL1B—Parkinson's disease	0.000477	0.00363	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000425	0.00323	CbGpPWpGaD
Fencamfamine—Tranylcypromine—CYP2D6—Parkinson's disease	0.000424	0.0598	CrCbGaD
Fencamfamine—SLC6A3—Parkinsons Disease Pathway—CASP3—Parkinson's disease	0.000415	0.00316	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000412	0.00313	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—GRIK1—Parkinson's disease	0.000383	0.00291	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—NQO1—Parkinson's disease	0.000352	0.00268	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—HSPA1A—Parkinson's disease	0.00035	0.00266	CbGpPWpGaD
Fencamfamine—SLC6A3—Monoamine Transport—TNF—Parkinson's disease	0.000346	0.00263	CbGpPWpGaD
Fencamfamine—SLC6A3—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000334	0.00254	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000326	0.00248	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—GRIK2—Parkinson's disease	0.000326	0.00248	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00032	0.00243	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00032	0.00243	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—SLC18A2—Parkinson's disease	0.000315	0.0024	CbGpPWpGaD
Fencamfamine—SLC6A3—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000307	0.00234	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000299	0.00227	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GSTP1—Parkinson's disease	0.000294	0.00224	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—HMOX1—Parkinson's disease	0.00029	0.00221	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00028	0.00213	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000274	0.00208	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—GSTM1—Parkinson's disease	0.00027	0.00206	CbGpPWpGaD
Fencamfamine—SLC6A3—NRF2 pathway—HGF—Parkinson's disease	0.00027	0.00206	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—CHRNA4—Parkinson's disease	0.00025	0.0019	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000229	0.00175	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—HSPA8—Parkinson's disease	0.000229	0.00174	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000228	0.00173	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—DLG4—Parkinson's disease	0.000215	0.00163	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—GRIN2B—Parkinson's disease	0.00021	0.0016	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—COMT—Parkinson's disease	0.000176	0.00134	CbGpPWpGaD
Fencamfamine—SLC6A3—Neuronal System—MAOA—Parkinson's disease	0.000175	0.00133	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00017	0.00129	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000156	0.00119	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000107	0.000813	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.28e-05	0.000706	CbGpPWpGaD
Fencamfamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.91e-05	0.000678	CbGpPWpGaD
